Taken together, Luminal A breast cancer with low DAB2IP expression is associated with increased cancer hallmark characteristics, including cell proliferation and metastasis, which may be due to increased NF-κB and enhanced ER signaling. Here, DAB2IP is linked to breast carcinoma.